There were 22% fewer people with kidney-related problems among the nearly 9,000-strong cohort taking weekly semaglutide injections compared to the group receiving a placebo, the researchers found, a relative incidence of 1.8% and 2.2%, respectively
A common dosing approach begins at 2.5 mg once weekly, with stepwise increases every 4 weeks as directed by your healthcare provider, up to a maximum dose of 15 mg once weekly
Nausea is common early or after dose increases, and while it tends to subside, it can impact which foods you can tolerate
Research evaluating retatrutide has produced promising results
Thanks Val, theres no test that separates these two situations
Metformin-induced reductions in tumor growth involves modulation of the gut microbiome